---
title: "How has the use of vaccinations changed over time?"
summary: "The use of vaccinations has evolved significantly over time, from crude methods to sophisticated, targeted immunisation strategies."
author: "Dr. Megan Harris"
degree: "PhD in Cellular Biology, University College London"
tutor_type: "IB Biology Tutor"
date: 2024-08-05
---

The field of vaccinations has undergone remarkable evolution from primitive techniques to highly advanced, targeted immunization strategies.

In the early stages of vaccination, the methods employed were quite basic. The first known vaccine, created by Edward Jenner in 1796, was aimed at smallpox. Jenner observed that milkmaids who had contracted cowpox were subsequently immune to smallpox. He hypothesized that exposure to cowpox conferred protection against smallpox and tested this theory by inoculating a young boy with cowpox pus. The boy developed mild symptoms of cowpox but remained healthy when later exposed to smallpox. This pivotal experiment marked the inception of vaccinations.

During the 19th and early 20th centuries, additional vaccines were developed for diseases such as rabies, diphtheria, and tetanus. However, these early vaccines frequently resulted in severe side effects and their efficacy was not consistently reliable. Furthermore, the production methods of these vaccines were not standardized, leading to significant variations in both quality and effectiveness.

The mid-20th century heralded significant advancements in vaccine development. A landmark achievement was the polio vaccine, introduced by Jonas Salk in 1955. This was the first vaccine to utilize a 'killed' virus, which proved to be safer than those made from live viruses. This innovative approach laid the groundwork for the creation of other inactivated vaccines. Around the same period, Albert Sabin developed an oral polio vaccine made from a weakened virus, which was easier to administer and provided prolonged immunity.

In recent decades, the administration of vaccinations has become increasingly widespread and systematic. Global vaccination programs have been established, targeting various demographics and age groups. The World Health Organization's Expanded Programme on Immunization, initiated in 1974, has been instrumental in enhancing global immunization coverage.

Technological advancements have also contributed to the development of more sophisticated vaccines. For instance, recombinant DNA technology has enabled the creation of vaccines against diseases such as Hepatitis B and Human Papillomavirus. These vaccines are produced by inserting a small segment of the pathogen's genetic material into another organism, prompting the production of an antigen that elicits an immune response.

The evolution of vaccinations has also been driven by the need to address emerging health threats. The swift development and worldwide distribution of COVID-19 vaccines serve as a testament to this adaptability. Never before have vaccines been developed and deployed on such a large scale and with such rapidity.

In conclusion, the landscape of vaccination has transformed dramatically over time, evolving from basic inoculation methods to complex immunization strategies. This ongoing evolution has been propelled by scientific breakthroughs and public health initiatives.
    